Corporate ActionAug 11, 2026, 05:18 PM
Tango Therapeutics Expands ATM Offering to $400M
AI Summary
Tango Therapeutics, Inc. has expanded its at-the-market (ATM) equity offering program. The company previously had an ATM program for up to $100 million, under which it sold approximately $64.4 million in shares, leaving $35.6 million unsold. A new prospectus supplement has been filed to offer up to $400 million in common stock, which includes the remaining $35.6 million from the prior program. The previous $100 million program has been terminated.
Key Highlights
- Previous at-the-market (ATM) program authorized up to $100,000,000.
- Approximately $64,389,566 of shares sold under the prior ATM program.
- Approximately $35,610,434 of shares remained unsold under the prior program.
- New ATM program authorizes the offer and sale of up to $400,000,000 in common stock.
- The new program includes the $35,610,434 unsold shares from the prior program.
- The prior $100,000,000 ATM program has been terminated.
Price Impact
More from TNGX